Updated guidance on botulinum toxin formulations for four indications
The American Academy of Neurology has issued an update to its 2008 guidelines on the use of botulinum toxin for the treatment of spasticity, cervical dystonia, blepharospasm and migraine headache. (Source: MedWire News)
Source: MedWire News - April 26, 2016 Category: Consumer Health News Tags: Neurology Source Type: news
AAN updates botulinum toxin guidelines for most established uses
VANCOUVER – A new American Academy of Neurology practice guideline on the efficacy and safety evidence for botulinum toxin treatment of blepharospasm, cervical dystonia, spasticity, and headache has... (Source: Family Practice News)
Source: Family Practice News - April 19, 2016 Category: Primary Care Source Type: news
AAN updates botulinum toxin guidelines for most established uses
VANCOUVER – A new American Academy of Neurology practice guideline on the efficacy and safety evidence for botulinum toxin treatment of blepharospasm, cervical dystonia, spasticity, and headache has... (Source: Clinical Neurology News)
Source: Clinical Neurology News - April 19, 2016 Category: Neurology Source Type: news
New AAN Guideline on Use of Botulinum NeurotoxinsNew AAN Guideline on Use of Botulinum Neurotoxins
The American Academy of Neurology has released new recommendations on the use of botulinum neurotoxin products in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 18, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Zonisamide relieves myoclonus dystonia motor symptoms
A randomised crossover trial shows that zonisamide significantly improves motor symptoms and related disability in adults with myoclonus dystonia. (Source: MedWire News)
Source: MedWire News - April 12, 2016 Category: Consumer Health News Tags: Movement disorders Source Type: news
This Treatment Could Alleviate Chronic Pain Without Opioid Medications
Researchers at the University of Texas at Arlington have been working on a new way to treat chronic pain -- and it just might help curb the rampant abuse of opioid medicines prescribed for pain management. Using a wireless device, the researchers demonstrated in lab rats how electrically stimulating an area hidden deep in the brain could relieve long-term pain. The method could offer a new way to alleviate chronic pain without the negative side effects of opioid medications, said Dr. Yuan Bo Peng, a psychology professor at the university and a corresponding author of the new research. Each day, more tha...
Source: Healthy Living - The Huffington Post - April 5, 2016 Category: Consumer Health News Source Type: news
This Treatment Could Alleviate Chronic Pain Without Opioid Medications
Researchers at the University of Texas at Arlington have been working on a new way to treat chronic pain -- and it just might help curb the rampant abuse of opioid medicines prescribed for pain management. Using a wireless device, the researchers demonstrated in lab rats how electrically stimulating an area hidden deep in the brain could relieve long-term pain. The method could offer a new way to alleviate chronic pain without the negative side effects of opioid medications, said Dr. Yuan Bo Peng, a psychology professor at the university and a corresponding author of the new research. Each day, more tha...
Source: Science - The Huffington Post - April 5, 2016 Category: Science Source Type: news
FDA Issues Draft Guidance For IDEs For Neurological Devices
The U.S. Food and Drug Administration (FDA) released a draft guidance for sponsors who wish to submit an investigational device exemption (IDE) to conduct trials for devices intended to slow, stop, or reverse the effects of neurological diseases, including Alzheimer's disease, Parkinson's disease, or primary dystonia. (Source: Medical Design Online News)
Source: Medical Design Online News - March 8, 2016 Category: Medical Equipment Source Type: news
Engineered Surface Tubing
Zeus offers Engineered Surface Tubing designed specifically for the neurostimulation treatment of Dystonia; a neurological movement disorder primarily related to Parkinson’s disease. This surface tubing features highly lubricated surfaces, making treatment delivery easier for surgeons and safer for patients. (Source: Medical Design Online Products)
Source: Medical Design Online Products - March 2, 2016 Category: Medical Equipment Source Type: news
International Perspectives: Clinical Kernicterus in Preterm Infants in Japan
In recent years, clinical kernicterus has been diagnosed in preterm infants on the basis of motor (kinetic) disorders such as choreoathetosis and dystonia, impairment in auditory neuropathy-type hearing, and abnormal pallidal signals on head magnetic resonance imaging. In Japan, it is currently estimated that at least 8 to 9 cases of kernicterus (approximately 2 per 1,000 cases) occur annually in preterm infants of less than 30 weeks’ gestation. Therefore, there is an urgent need to revise our jaundice management approach in preterm infants. Two major characteristics of Japanese preterm infants who develop clinical k...
Source: NeoReviews recent issues - March 1, 2016 Category: Pediatrics Authors: Morioka, I., Nakamura, H., Iwatani, S., Wong, R. J., Iijima, K. Tags: Pediatric Drug Labeling Update Articles Source Type: news
Researchers hope brain's plasticity can be used to treat disorders
Exactly what triggers dystonia — an involuntary muscle contraction of the hand, fingers, neck or mouth, which is sometimes very painful — is unclear. But some researchers think the underlying problem that causes it may also be the key to treating it, and other brain-linked disorders like Parkinson's. (Source: CBC | Health)
Source: CBC | Health - February 25, 2016 Category: Consumer Health News Tags: News/Health Source Type: news
Intensive instrument playing can lead to movement disorders
(Deutsches Aerzteblatt International) In total, one in 6,600 persons will develop focal dystonia, whereas an estimated one in 100 musicians will succumb. This is the finding of an original article by Verena Eveline Rozanski and coauthors in the current issue of Deutsches Ärzteblatt International. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2016 Category: Global & Universal Source Type: news
Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
An overdose of Guaifenesin DM may cause hyper excitability, rapid eye movements, changes in muscle reflexes, ataxia, dystonia, hallucinations, stupor, and coma. (Source: FDA MedWatch)
Source: FDA MedWatch - January 13, 2016 Category: American Health Source Type: news
VIDEO: 'Disability doesn't mean anything'
A model with cerebral palsy and dystonia is having deep-brain surgery which she hopes will help with mobility and is on a mission to fight misconceptions about disability. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 13, 2016 Category: Consumer Health News Source Type: news
Recall Issued For Children’s Cold Medicine
BOSTON (CBS) — A recall for a children’s cold medicine sold by retailers like CVS and Stop and Shop has been issued.
In a release posted on the company’s website, Perrigo Company said they had issued a recall for two batches of their children’s guaifenesin grape liquid and three batches of their children’s guaifenesin DM cherry liquid. Both products are sold in 4 oz. bottles with a dosage cup included in the package. The recall was issued because the markings on some of the dosage cups are inaccurate–which could lead to overdoses.
“There have been no reports of adverse events to...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 12, 2016 Category: Consumer Health News Authors: Jon Palmer Tags: Health Local News Syndicated Local drug recall Perrigo Source Type: news
